{"id":"https://openalex.org/W3212373000","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.571","title":"571 IL-2 combination with ImmTAC overcomes CD163+ TAM-like M2 macrophage inhibition of ImmTAC-mediated T cell killing of tumor cells","display_name":"571 IL-2 combination with ImmTAC overcomes CD163+ TAM-like M2 macrophage inhibition of ImmTAC-mediated T cell killing of tumor cells","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3212373000","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.571","mag":"3212373000"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.571","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.571","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.571","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A600.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A600.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082507150","display_name":"Rahul C. Khanolkar","orcid":"https://orcid.org/0009-0001-0037-3013","observed_orcids":["https://orcid.org/0009-0001-0037-3013"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rahul Khanolkar","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019721864","display_name":"Revashnee Naidoo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Revashnee Naidoo","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040173992","display_name":"Esra G\u00fc\u00e7","orcid":"https://orcid.org/0000-0002-3172-5958","observed_orcids":["https://orcid.org/0000-0002-3172-5958"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Esra G\u00fc\u00e7","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044773629","display_name":"Emma Leach","orcid":"https://orcid.org/0000-0002-2831-092X","observed_orcids":["https://orcid.org/0000-0002-2831-092X"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emma Leach","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060489370","display_name":"Sarah Stanhope","orcid":"https://orcid.org/0000-0002-7660-3591","observed_orcids":["https://orcid.org/0000-0002-7660-3591"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Stanhope","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084005845","display_name":"Duncan M. Gascoyne","orcid":"https://orcid.org/0000-0001-7879-374X","observed_orcids":["https://orcid.org/0000-0001-7879-374X"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Duncan Gascoyne","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008634635","display_name":"Laura E. Collins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura Collins","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904667","display_name":"Koustubh Ranade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Koustubh Ranade","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056485122","display_name":"Adel Benlahrech","orcid":"https://orcid.org/0009-0003-3174-482X","observed_orcids":["https://orcid.org/0009-0003-3174-482X"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adel Benlahrech","raw_affiliation_strings":["Immunocore, Abingdon, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocore, Abingdon, UK","institution_ids":["https://openalex.org/I4210104024"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210104024"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A600","last_page":"A600"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.6128000020980835,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.6128000020980835,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.3041999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.02449999935925007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immtac","display_name":"ImmTAC","score":0.9649999737739563},{"id":"https://openalex.org/keywords/tebentafusp","display_name":"tebentafusp","score":0.8759999871253967},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8989999890327454},{"id":"https://openalex.org/keywords/il-15","display_name":"IL-15","score":0.968999981880188},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9169999957084656},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.8899999856948853},{"id":"https://openalex.org/keywords/cd163","display_name":"CD163","score":0.9100000262260437},{"id":"https://openalex.org/keywords/t-cell-redirection","display_name":"T cell redirection","score":0.6949999928474426},{"id":"https://openalex.org/keywords/t-cell-mediated-killing","display_name":"T cell-mediated killing","score":0.5690000057220459},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5910000205039978},{"id":"https://openalex.org/keywords/metastatic-uveal-melanoma","display_name":"metastatic uveal melanoma","score":0.8859999775886536},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.7429999709129333},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.5360000133514404},{"id":"https://openalex.org/keywords/tumor-shrinkage","display_name":"tumor shrinkage","score":0.49399998784065247},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9340000152587891},{"id":"https://openalex.org/keywords/m1-macrophages","display_name":"M1 macrophages","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C2775858924","wikidata":"https://www.wikidata.org/wiki/Q18034009","display_name":"CD163","level":4,"score":0.8307137489318848},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5498932003974915},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.540527880191803},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5185197591781616},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5078886151313782},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.5046578645706177},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4886968433856964},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.46804308891296387},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.43298962712287903},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.39405158162117004},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3895914554595947},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37646061182022095},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2934873700141907},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2862894833087921},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.571","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.571","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.571","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A600.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:efe704b395a44aa6a3ca56cd2e01c49f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/efe704b395a44aa6a3ca56cd2e01c49f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.571","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.571","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.571","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A600.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3212373000.pdf","grobid_xml":"https://content.openalex.org/works/W3212373000.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W3177742807","https://openalex.org/W3178166868"],"related_works":["https://openalex.org/W4408282309","https://openalex.org/W4387812186","https://openalex.org/W3178166868","https://openalex.org/W3104404795","https://openalex.org/W4415900201","https://openalex.org/W4295837033","https://openalex.org/W4362592628","https://openalex.org/W3203186652","https://openalex.org/W7162547177","https://openalex.org/W4388048347"],"abstract_inverted_index":{"Background":[0],"ImmTAC":[1,390],"molecules":[2,391],"are":[3],"bispecific":[4],"fusion":[5],"proteins":[6],"consisting":[7],"of":[8,79,94,179,189,245,265,270,276,283,290,299,370,400],"an":[9,16,373],"affinity-enhanced":[10],"T":[11,22,56,74,112,145,157,176,234,246,267,330,367],"cell":[12,57,146,177,235,247,268,331,368],"receptor":[13],"fused":[14],"to":[15,24,76,106,118,328,387,392,492],"anti-CD3":[17],"effector":[18],"that":[19,43],"can":[20],"redirect":[21],"cells":[23,75,113,158,181,272],"target":[25],"cells.":[26,156],"Tebentafusp,":[27],"a":[28,44,48,90,356],"gp100-directed":[29],"ImmTAC,":[30],"has":[31],"demonstrated":[32],"survival":[33,218,470],"benefit":[34,63,394],"in":[35,134,186,224,230,261,273,315,337,349,355,395,425,456],"metastatic":[36,95,351,428],"uveal":[37,96,352,429],"melanoma":[38,97,353,449],"[1].":[39],"We":[40,227],"previously":[41],"reported":[42],"tumor":[45,149,155,180,208,271,371,457,465],"microenvironment":[46],"with":[47,61,101,166,197,206,294,319,343,389,397,422,452],"high":[49,334,398],"immunosuppressive":[50],"CD163+":[51,108,326],"tumor-associated":[52],"macrophage":[53],"(TAM):":[54],"CD3":[55,329],"ratio":[58,203,212,221,332,455],"was":[59,151,182,204,317,490,501],"associated":[60,205,318,342],"reduced":[62,183],"from":[64,89,136],"tebentafusp":[65,102,421],"[2].":[66],"Here,":[67],"we":[68],"explored":[69,229],"whether":[70,232],"IL-2":[71,169,238,255,385],"could":[72,241],"potentiate":[73],"overcome":[77,242],"inhibition":[78,244],"ImmTAC-mediated":[80,144,175,266,366],"killing":[81,150,178,269,284,369],"by":[82,114,122,184,249,376,504],"TAM-like":[83,129,190,277,362],"M2":[84,130,191,278,363],"macrophages.":[85,195],"Methods":[86],"Tumor":[87],"biopsies":[88],"Phase":[91,357,416],"2":[92,358],"trial":[93,419],"HLA-A*02:01+":[98],"patients":[99,354,451],"treated":[100],"(NCT02570308)":[103],"were":[104,132,159,341],"used":[105,491],"quantify":[107],"TAMs":[109],"and":[110,117,128,140,148,215,239,280,287,304,333,346,459,468,500],"CD3+":[111],"immunohistochemistry":[115],"(N=107)":[116],"measure":[119],"gene":[120],"expression":[121,298,336],"bulk":[123],"RNAseq":[124],"(N=70).":[125],"Pro-inflammatory":[126],"M1":[127,194],"macrophages":[131,364],"generated":[133],"vitro":[135,231],"healthy":[137],"donors":[138],"(N=5)":[139],"their":[141],"effect":[142,374],"on":[143,322,472],"activation":[147],"assessed":[152],"against":[153],"THP-1":[154],"untreated":[160],"or":[161,170],"pre-treated":[162],"for":[163,383,496],"4":[164],"days":[165],"commercially":[167],"sourced":[168],"IL-15.":[171],"Results":[172],"In":[173,360],"vitro,":[174,361],"85\u00b15%":[185],"the":[187,233,274,505],"presence":[188,275],"but":[192,256,309],"not":[193,257,310],"Consistent":[196,293],"this":[198,295],"finding,":[199],"below":[200],"median":[201],"CD163:CD3":[202,454],"greater":[207,347],"shrinkage":[209,466],"(TS)":[210,467],"(odds":[211],"OR=2.9,":[213],"p=0.014)":[214],"longer":[216,320,344],"overall":[217,469],"(OS)":[219,471],"(hazard":[220],"HR=0.4,":[222],"p=0.001)":[223],"tebentafusp-treated":[225,350],"patients.":[226],"next":[228],"activating":[236],"cytokines":[237],"IL-15":[240,258],"TAM-mediated":[243],"redirection":[248],"ImmTAC.":[250],"At":[251],"clinically":[252],"relevant":[253],"doses,":[254],"treatment":[259],"resulted":[260],"dose":[262],"dependent":[263],"restoration":[264,282],"macrophages\u201460%":[279],"83%":[281],"at":[285,339],"50":[286],"150":[288],"U/ml":[289],"IL-2,":[291],"respectively.":[292],"observation,":[296],"increased":[297],"IL2RB":[300],"(HR":[301,306,312],"0.3,":[302],"p<0.001)":[303],"IL2RG":[305],"0.4,":[307],"p=0.002),":[308],"IL2RA":[311],"0.8,":[313],"p=0.5)":[314],"tumors":[316,338,396],"OS":[321,345],"tebentafusp.":[323,473],"Conclusions":[324],"Low":[325],"TAM":[327],"IL2RB/G":[335,388],"baseline":[340],"TS":[348],"trial.":[359],"suppressed":[365],"cells,":[372],"abrogated":[375],"IL-2.":[377],"These":[378],"observations":[379],"provide":[380],"strong":[381],"rationale":[382],"combining":[384],"biased":[386],"enhance":[393],"levels":[399],"TAMs.":[401],"Trial":[402],"Registration":[403],"NCT02570308":[404],"References":[405],"Piperno-Neumann":[406],"S,":[407,443],"Hassel":[408,438],"JC,":[409,439],"Rutkowski":[410],"P":[411],"et":[412,444],"al.":[413,445],"Abstract":[414,446],"CT002:":[415],"3":[417],"randomized":[418],"comparing":[420],"investigator\u2019s":[423],"choice":[424],"first":[426],"line":[427],"melanoma.":[430],"Cancer":[431,474],"Res.":[432,475],"2021;":[433,476],"81":[434,477],"(13":[435,478],"Supplement)":[436,479],"CT002.":[437],"Benlahrech":[440],"A,":[441],"Stanhope":[442],"1673:":[447],"Uveal":[448],"study":[450],"low":[453,460],"biopsy":[458],"serum":[461],"IL-6":[462],"showed":[463],"enhanced":[464],"1673.":[480],"Ethics":[481,508],"Approval":[482],"The":[483],"Oxford":[484],"A":[485],"REC":[486],"approved":[487,503],"protocol":[488],"13/SC/0226":[489],"obtain":[493],"written":[494],"consent":[495],"all":[497],"blood":[498],"donations":[499],"fully":[502],"National":[506],"Research":[507],"Committee":[509],"South":[510],"Central.":[511]},"counts_by_year":[{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-11-22T00:00:00"}